Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis.

Trial Profile

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Mar 2010 Results were presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 09 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top